Tatva Chintan Pharma Chem Ltd

NSE: TATVA · BSE: 543321 · Chemicals & Petrochemicals · 28 announcements

Tatva Chintan Pharma Chem Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,991.20
Market cap: ₹4,658 Cr
Revenue (annual): ₹505.9 Cr
Net profit (annual): ₹42.05 Cr
P/E (TTM): 90.7×Sector 36.8×
Promoter holding: 72.02%+0.00% QoQ
FII holding: 3.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Other Announcement 3 Financial Results 3 Annual General Meeting 3 Management Change 2 Debt & Borrowing 2 Capacity Expansion 2 Board Meeting Date 2 Dividend 1 Credit Rating 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

16 May 2026 15:41 IST NSE

Board Meeting Outcome

Tatva Chintan Pharma Chem Board Meeting Outcome

Tatva Chintan Pharma's board re-appointed RSM Astute and Zarna Thakar & Associates as auditors. The appointments are effective from April 2026 for twelve months.

Execution: 12 months

Read the filing ↗